Literature DB >> 6489412

Chlorpropamide-alcohol flush: significance of body weight, sex and serum chlorpropamide level.

L Groop, C J Eriksson, E Wåhlin-Boll, A Melander.   

Abstract

Chlorpropamide-alcohol flush (CPAF) tests were carried out in 15 male and 15 female Type 2 diabetics. Twelve subjects were CPAF-positive and 18 were -negative. The two groups did not differ in age or duration of diabetes, but the CPAF-positive subjects weighed less (mean difference 13 kg) and had higher plasma chlorpropamide levels. There was a negative correlation between plasma chlorpropamide and body weight, and a positive correlation between plasma chlorpropamide and the increase in facial skin temperature. Females had higher plasma chlorpropamide, a greater skin temperature increase and lower body weight than males; there were 11 females and only 1 male amongst the 12 CPAF-positive subjects. The findings confirm that plasma chlorpropamide is a major determinant of the CPAF reaction and also show that body weight strongly influences the chlorpropamide level and, consequently, the outcome of the CPAF test. The sex difference in body weight probably accounts for most, if not all, of the sex difference in the incidence of the CPAF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489412     DOI: 10.1007/bf00541932

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Is the blood chlorpropamide concentration critical in chlorpropamide alcohol flush?

Authors:  P Jerntorp; L O Almér; A Melander
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

2.  Chlorpropamide alcohol flushing and diabetic retinopathy.

Authors:  R D Leslie; A H Barnett; D A Pyke
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

3.  Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics.

Authors:  A H Barnett; R D Leslie; D A Pyke
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

4.  The prevalence of chlorpropamide alcohol flushing in non-insulin dependent diabetics.

Authors:  P Micossi
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

5.  Chlorpropamide-alcohol flushing: a dominantly inherited trait associated with diabetes.

Authors:  R D Leslie; D A Pyke
Journal:  Br Med J       Date:  1978-12-02

6.  Chlorpropamide-alcohol flushing in relation to macroangiopathy and peripheral neuropathy in non-insulin dependent diabetes.

Authors:  P Jerntorp; L O Almér
Journal:  Acta Med Scand Suppl       Date:  1981

7.  Epidemiological study of prevalence of chlorpropamide alcohol flushing in insulin dependent diabetics, non-insulin dependent diabetics, and non-diabetics.

Authors:  S Ng Tang Fui; H Keen; R J Jarrett; C Strakosch; T Murrells; P Marsden; R Stott
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

8.  Increase of plasma acetaldehyde. An objective indicator of the chlorpropamide alcohol flush.

Authors:  P Jerntorp; H Ohlin; B Bergström; L O Almér
Journal:  Diabetes       Date:  1981-09       Impact factor: 9.461

9.  The chlorpropamide alcohol flush. Lack of specificity for familial non-insulin dependent diabetes.

Authors:  J Köbberling; N Bengsch; B Brüggeboes; H Schwarck; H Tillil; M Weber
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

10.  Chlorpropamide-alcohol flushing and large-vessel disease in non-insulin-dependent diabetes.

Authors:  A H Barnett; D A Pyke
Journal:  Br Med J       Date:  1980-07-26
View more
  1 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.